Now Available: Final Rule for FDAAA 801 and NIH Policy on Clinical Trial Reporting

The Significance of MRI in the Development of Diagnostics and Treatment of Breast Cancer

The recruitment status of this study is unknown because the information has not been verified recently.
Verified November 2011 by Turku University Hospital.
Recruitment status was  Recruiting
Information provided by (Responsible Party):
Turku University Hospital Identifier:
First received: November 30, 2011
Last updated: December 1, 2011
Last verified: November 2011
The purpose of this study is to determine how MRI changes the treatment and diagnostics of ductal breast cancer. 100 women with newly diagnosed breast cancer will participate the study.

Mammary Ductal Carcinoma

Study Type: Observational
Study Design: Observational Model: Case Control
Time Perspective: Prospective

Resource links provided by NLM:

Further study details as provided by Turku University Hospital:

Estimated Enrollment: 100
Study Start Date: February 2011
No treatment


Ages Eligible for Study:   Child, Adult, Senior
Genders Eligible for Study:   Female
Accepts Healthy Volunteers:   Yes
Sampling Method:   Non-Probability Sample
Study Population
Newly diagnosted breast cancer patients

Inclusion Criteria:

  • Tumor size less than 2cm
  • Ductal carcinoma unifocal

Exclusion Criteria:

  • Previous breast cancer
  Contacts and Locations
Choosing to participate in a study is an important personal decision. Talk with your doctor and family members or friends about deciding to join a study. To learn more about this study, you or your doctor may contact the study research staff using the Contacts provided below. For general information, see Learn About Clinical Studies.

Please refer to this study by its identifier: NCT01484704

Contact: Nina M Brück, MD +35823130544

University hospital of Turku Recruiting
Turku, Finland, 20521
Contact: Nina M Brück, MD   
Principal Investigator: Nina M Brück, MD         
Sponsors and Collaborators
Turku University Hospital
  More Information

Responsible Party: Turku University Hospital Identifier: NCT01484704     History of Changes
Other Study ID Numbers: 63/180/2010 
Study First Received: November 30, 2011
Last Updated: December 1, 2011
Health Authority: Finland: Ethics Committee

Keywords provided by Turku University Hospital:
Carcinoma ductale mammae

Additional relevant MeSH terms:
Carcinoma, Ductal
Carcinoma, Ductal, Breast
Neoplasms, Glandular and Epithelial
Neoplasms by Histologic Type
Neoplasms, Ductal, Lobular, and Medullary
Breast Neoplasms
Neoplasms by Site
Breast Diseases
Skin Diseases processed this record on October 21, 2016